Zubair Khalid

Virologist/Molecular Biologist | Veterinarian | Bioinformatician

Conventional & Molecular Virology • Vaccine Development • Computational Biology

Dr. Zubair Khalid is a veterinarian and virologist specializing in conventional and molecular virology, vaccine development, and computational biology. Dedicated to advancing animal health through innovative research and multi-omics approaches.

Dr. Zubair Khalid - Veterinarian, Virologist, and Vaccine Development Researcher specializing in Computational Biology, Multi-omics, Animal Health, and Infectious Disease Research

Section: Molecular Diagnostics

Transwell Migration Assay Protocol: Measuring Cell Migration and Invasion

The Science Laboratory at the Aspatria Agricultural college
Image by Unknown author Unknown author, Wikimedia Commons, licensed under Public domain.

The Transwell migration assay, also known as the Boyden chamber assay, is a cell-based laboratory method used to quantify the directional movement of cells through a porous membrane in response to a chemoattractant gradient. This assay is useful for studying cell motility under controlled conditions, evaluating the effects of drugs or genetic manipulations on migration and invasion, and investigating mechanisms underlying metastasis, wound healing, and immune cell trafficking. The protocol involves seeding cells into an upper chamber with a permeable membrane, allowing them to migrate toward a chemoattractant in the lower chamber, then fixing, staining, and counting the cells that have traversed the membrane.

At a Glance

Aspect Details
Purpose Quantify cell migration (uncoated membrane) or invasion (extracellular matrix-coated membrane)
Principle Cells migrate through porous membrane toward chemoattractant gradient
Key Materials Transwell inserts, multiwell plate, chemoattractant, fixation/stain reagents
Cell Types Adherent or suspension cells (e.g., cancer cell lines, primary cells)
Assay Time 4–48 hours depending on cell type and membrane coating
Readout Number of migrated/invaded cells per field or total per membrane
Controls Required Negative control (no chemoattractant), positive control (known chemoattractant), vehicle control
Biosafety Level BSL-1 for non-pathogenic cell lines; BSL-2 for human primary cells or transformed lines

Scientific Principle

The Transwell assay exploits the ability of cells to sense and move along a concentration gradient of soluble factors. A Transwell insert—a small cup with a porous membrane at its base—is placed into a well of a tissue culture plate. Cells are seeded into the upper chamber in serum-free or low-serum medium, while the lower chamber contains medium supplemented with a chemoattractant such as fetal bovine serum (FBS), growth factors, or conditioned medium. Over the incubation period, cells that are capable of migration extend protrusions through the membrane pores and move to the underside of the membrane. The number of cells that successfully traverse the membrane is proportional to their migratory capacity.

For invasion assays, the membrane is pre-coated with a thin layer of extracellular matrix (ECM) proteins such as Matrigel, collagen, or fibronectin. Cells must enzymatically degrade this barrier before migrating, providing a model of the invasive behavior seen in metastatic cancer cells. Studies using Matrigel-coated Transwell assays have demonstrated that compounds like curcumin can reduce invasive activity in prostate cancer cells, as assessed by counting cells that penetrated the matrix barrier [2].

The pore size of the membrane is critical: typically 8 μm for most adherent cell lines, 3 μm for lymphocytes, and 12 μm for larger cells. The chemoattractant gradient is established by diffusion and remains stable for several hours, though prolonged incubation may lead to gradient dissipation.

Materials and Instrumentation

Transwell Inserts and Plates

Choose inserts based on pore size, membrane material, and plate format. Polycarbonate membranes are transparent and allow direct microscopic visualization, while polyethylene terephthalate (PET) membranes are more rigid and suitable for staining protocols. Common formats include 24-well plates with 6.5 mm diameter inserts and 96-well plates with smaller inserts for higher throughput.

Cell Culture Reagents

  • Complete growth medium appropriate for the cell type
  • Serum-free or low-serum medium (typically 0.1–0.5% FBS)
  • Chemoattractant: 10% FBS, specific growth factors (e.g., EGF, VEGF), or conditioned medium
  • Phosphate-buffered saline (PBS), calcium- and magnesium-free
  • Trypsin-EDTA or cell dissociation reagent
  • Counting reagents (trypan blue, hemocytometer, or automated counter)

Coating Materials for Invasion Assays

  • Matrigel (growth factor-reduced recommended for consistency)
  • Collagen type I or IV
  • Fibronectin
  • Gelatin

Fixation and Staining Solutions

  • 4% paraformaldehyde or 100% methanol for fixation
  • 0.1–0.5% crystal violet in 20% methanol
  • Hematoxylin and eosin (H&E) for nuclear and cytoplasmic staining
  • DAPI or Hoechst 33342 for fluorescence-based counting
  • Cotton swabs for removing non-migrated cells from the upper chamber

Equipment

  • Tissue culture incubator (37°C, 5% CO₂, humidified)
  • Laminar flow biosafety cabinet (Class II, Type A2)
  • Inverted light microscope with 10× or 20× objective
  • Microscope camera and image analysis software
  • Centrifuge for cell pelleting
  • Automated cell counter or hemocytometer

Controls

Proper controls are essential for interpreting Transwell assay results. Include the following in every experiment:

Negative control (no chemoattractant): Add serum-free medium to the lower chamber. This establishes baseline random migration and accounts for passive cell movement through the membrane.

Positive control: Use a known chemoattractant such as 10–20% FBS or a specific growth factor. This confirms that the assay system is functional and that cells are capable of directed migration.

Vehicle control: If testing a drug or compound, include a control where cells are treated with the vehicle (e.g., DMSO at the same final concentration) to rule out solvent effects on migration.

Cell viability control: Perform a parallel viability assay (e.g., MTS, CCK-8, or trypan blue exclusion) at the same time point to ensure that any observed reduction in migration is not due to cytotoxicity. Studies investigating the effects of compounds on migration routinely use sub-cytotoxic concentrations determined by viability assays [2].

Coating control (invasion assays): Include an uncoated insert with the same cell treatment to distinguish effects on invasion from effects on migration alone.

Conceptual Workflow

Step 1: Cell Preparation

Culture cells to 70–80% confluence in complete medium. On the day of the assay, starve cells in serum-free medium for 6–24 hours to reduce background proliferation and synchronize cell cycle status. For adherent cells, detach using trypsin-EDTA, then wash twice with serum-free medium to remove residual serum. Count cells and adjust to the desired concentration, typically 1–5 × 10⁵ cells/mL depending on cell type and insert size.

Step 2: Membrane Coating (Invasion Assay Only)

Dilute Matrigel or other ECM protein in ice-cold serum-free medium to the recommended concentration (typically 200–500 μg/mL). Add 50–100 μL to the upper chamber of each insert, ensuring complete coverage of the membrane. Incubate at 37°C for 1–2 hours to allow gelation. Aspirate any excess liquid carefully without disturbing the gel layer. For migration assays without coating, proceed directly to Step 3.

Step 3: Assembling the Assay

Add chemoattractant-containing medium to the lower chamber (typically 600 μL for a 24-well plate). Place the Transwell insert into the well, ensuring no air bubbles are trapped beneath the membrane. Add 100–200 μL of cell suspension to the upper chamber. For each condition, prepare at least triplicate inserts.

Step 4: Incubation

Incubate at 37°C, 5% CO₂ for 4–48 hours. The optimal time depends on cell type and membrane coating. For highly migratory cells like fibroblasts or aggressive cancer lines, 6–12 hours may suffice. For slower cells or invasion assays, 24–48 hours may be required. Do not exceed 48 hours, as cells may begin to proliferate on the underside of the membrane, confounding results.

Step 5: Fixation and Staining

Remove inserts from the plate and discard medium from the upper chamber. Gently rinse inserts in PBS. Fix cells by immersing inserts in 4% paraformaldehyde for 10–15 minutes at room temperature, or in 100% methanol for 5 minutes. After fixation, rinse again in PBS.

For crystal violet staining, immerse inserts in 0.1–0.5% crystal violet solution for 10–20 minutes. Rinse thoroughly in distilled water to remove excess stain. For fluorescence-based counting, stain with DAPI (1 μg/mL in PBS) for 5–10 minutes, then rinse.

Step 6: Removing Non-Migrated Cells

Use a cotton swab to gently scrub the upper surface of the membrane, removing cells that did not migrate. Be careful not to press through the membrane. For invasion assays, this step removes both non-migrated cells and residual Matrigel. Rinse the upper chamber with PBS after swabbing.

Step 7: Quantification

For crystal violet-stained membranes, cut the membrane from the insert using a scalpel or allow it to air-dry in the insert. Mount on a glass slide with the migrated side facing up. Count cells in 5–10 random fields per membrane using a 10× or 20× objective. Alternatively, elute crystal violet by immersing the membrane in 10% acetic acid or 100% methanol and measure absorbance at 590 nm.

For fluorescence-stained membranes, image using a fluorescence microscope and count nuclei using image analysis software. Automated counting is more reproducible than manual counting.

Quality Checks

Perform the following quality checks to ensure assay validity:

Membrane integrity: Inspect inserts before use for tears, wrinkles, or incomplete coating. Damaged membranes allow non-specific cell passage.

Cell viability post-assay: Collect cells from the upper chamber after incubation and assess viability using trypan blue exclusion. Greater than 90% viability indicates that the assay conditions are not cytotoxic.

Gradient verification: For critical experiments, confirm that a chemoattractant gradient exists by measuring chemoattractant concentration in upper and lower chambers at the end of the incubation period.

Inter-insert variability: Calculate the coefficient of variation (CV) for replicate inserts. CV values below 20% indicate acceptable technical reproducibility.

Positive control performance: The positive control should show at least 3–5 fold more migrated cells than the negative control. If not, troubleshoot the chemoattractant concentration, incubation time, or cell health.

Result Interpretation

Results are typically expressed as the mean number of migrated cells per field or per membrane, normalized to the negative control. For drug treatment studies, calculate the percentage of migration relative to the vehicle control:

% Migration = (Migrated cells in treated group / Migrated cells in vehicle control) × 100

A reduction in migration indicates an inhibitory effect, while an increase suggests enhanced motility. In invasion assays, the number of cells that penetrate the ECM-coated membrane is typically lower than for uncoated membranes, reflecting the additional barrier. Comparing migration and invasion under the same conditions can reveal whether a treatment specifically affects invasive capacity.

Statistical analysis should use appropriate tests such as one-way ANOVA with post-hoc comparisons for multiple groups, or Student's t-test for two-group comparisons. Report data as mean ± standard deviation (SD) or standard error of the mean (SEM) from at least three independent experiments.

Troubleshooting

Observation Likely Cause Discriminating Check
No cells migrated in any condition Incubation time too short Repeat with longer incubation (e.g., 24 h instead of 6 h)
Chemoattractant inactive or degraded Prepare fresh chemoattractant; test with known responsive cell line
Pore size too small for cell type Verify cell diameter; use 8 μm for most adherent cells
High background in negative control Passive diffusion due to damaged membrane Inspect membrane under microscope before use
Cells too dense in upper chamber Reduce seeding density by 50%
Incubation time too long Shorten incubation; check at 4 h intervals
Uneven cell distribution across membrane Air bubbles trapped under insert Re-insert carefully; tilt insert to release bubbles
Uneven coating of ECM Ensure even spreading; use cold reagents for Matrigel
Cells detach during swabbing Incomplete fixation Increase fixation time to 20 min
Swabbing too vigorously Use gentle circular motion; pre-wet swab in PBS
Low cell numbers in positive control Cells unhealthy or senescent Check cell passage number; use cells below passage 20
Chemoattractant concentration too low Titrate FBS from 5% to 20% to find optimal
High variability between replicates Inconsistent cell counting Use automated counter; prepare master cell suspension
Inconsistent staining/elution Standardize staining time; elute in same volume

Limitations

The Transwell assay has several limitations that researchers should consider when designing experiments and interpreting results.

Endpoint measurement: The assay provides a snapshot of migration at a single time point and does not capture dynamic cell behavior or migration speed. Real-time imaging systems can partially address this but require specialized equipment.

Gradient instability: The chemoattractant gradient is established by diffusion and dissipates over time. After 12–24 hours, the gradient may become negligible, potentially underestimating migration in slower cells.

Cell proliferation confounding: During long incubations (24–48 hours), cells may proliferate on the underside of the membrane, leading to overestimation of migration. Including a proliferation control (e.g., parallel culture without a gradient) can help distinguish migration from proliferation.

Matrix variability: For invasion assays, commercial Matrigel batches vary in protein composition and gelation properties. Using growth factor-reduced Matrigel and testing multiple batches can improve reproducibility.

Two-dimensional substrate: The assay uses a flat membrane, which does not fully recapitulate the three-dimensional extracellular environment encountered by cells in vivo. Results should be validated with complementary assays such as 3D spheroid invasion or organotypic models.

Cell type specificity: Optimal conditions (seeding density, incubation time, pore size) must be determined empirically for each cell type. Conditions that work for one cell line may not transfer to another.

Documentation

Maintain detailed records of all Transwell assay experiments to ensure reproducibility and compliance with laboratory standards. Document the following information:

Cell information: Cell line, passage number, source, culture conditions, and date of last thaw.

Assay conditions: Seeding density, serum concentration in upper and lower chambers, chemoattractant type and concentration, coating material and concentration, incubation time and temperature.

Reagent details: Manufacturer, catalog number, lot number, and expiration date for all reagents including Matrigel, stains, and chemoattractants.

Equipment settings: Microscope model, objective magnification, number of fields counted, image analysis software and parameters.

Raw data: Cell counts per field for each replicate, calculated means and standard deviations, statistical test results.

Deviations: Any modifications to the standard protocol, including changes in incubation time, staining method, or quantification approach.

Store images of representative fields for each condition as digital files with appropriate metadata. For publication, include at least three independent experiments with representative images and quantitative data.

Biosafety

The Transwell migration assay typically involves handling of mammalian cell lines, many of which are classified as BSL-1 or BSL-2 agents. Follow institutional biosafety guidelines and the principles outlined in the Biosafety in Microbiological and Biomedical Laboratories (BMBL) manual [6].

BSL-1 routine: For non-pathogenic, well-characterized cell lines (e.g., NIH/3T3, HEK 293), standard BSL-1 practices apply. Work in a Class II biosafety cabinet, use personal protective equipment (lab coat, gloves), and decontaminate all waste with 10% bleach or appropriate disinfectant.

BSL-2 considerations: Human cancer cell lines, primary cells, or cells transformed with viral vectors may require BSL-2 containment. Check institutional biosafety committee approvals and follow BSL-2 practices including restricted access, biohazard signage, and use of sharps containers.

Recombinant nucleic acids: If cells have been genetically modified with recombinant or synthetic nucleic acid molecules, consult the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules [7]. Experiments may require Institutional Biosafety Committee (IBC) approval and adherence to specific containment levels.

Chemical hazards: Fixatives (paraformaldehyde, methanol) and stains (crystal violet) are hazardous. Work in a chemical fume hood or biosafety cabinet, and dispose of chemical waste according to institutional hazardous waste protocols.

Decontamination: After the assay, decontaminate all used inserts, plates, and pipette tips by autoclaving or immersion in 10% bleach for at least 30 minutes before disposal.

Frequently Asked Questions

Q1: What is the difference between a migration assay and an invasion assay? A migration assay uses an uncoated porous membrane and measures the ability of cells to move toward a chemoattractant. An invasion assay uses a membrane coated with extracellular matrix proteins such as Matrigel, requiring cells to enzymatically degrade this barrier before migrating. Invasion assays better model the metastatic process where cancer cells must penetrate basement membranes.

Q2: How do I choose the optimal incubation time for my cell type? Perform a time-course experiment with your specific cell type and chemoattractant. Seed identical inserts and fix/stain them at 4, 8, 12, 24, and 48 hours. Choose the time point where the positive control shows robust migration (50–200 cells per field) while the negative control remains low (fewer than 20 cells per field). For most cancer cell lines, 12–24 hours is appropriate.

Q3: Can I use the Transwell assay for non-adherent cells like lymphocytes? Yes, but modifications are needed. Use inserts with smaller pore sizes (3 μm for lymphocytes) and shorter incubation times (2–6 hours). Pre-coat the membrane with fibronectin or collagen to promote adhesion after migration. Centrifuge the plate briefly after seeding to ensure cells contact the membrane.

Q4: How do I normalize migration data when comparing different cell lines? Normalize to the negative control (random migration) for each cell line individually. Express results as fold change over the negative control. Alternatively, normalize to cell number by counting cells from parallel wells at the time of seeding. For drug treatments, always include a vehicle control and express results as percentage of control migration.

References and Further Reading

  1. Du Y, Han H, Dong Y, et al. Ebracteolata cpd B causes ferroptosis and inhibits progression of lung adenocarcinoma. 2026. PubMed ID: 42137330. https://pubmed.ncbi.nlm.nih.gov/42137330/

  2. Cho MD, Chou SY, Hsu YM, et al. Curcumin Attenuates LPS-Induced Migration/EMT and LPS/ATP-Associated IL-1β Release in Androgen-Independent Prostate Cancer Cells. 2026. PubMed ID: 42042073. https://pubmed.ncbi.nlm.nih.gov/42042073/

  3. Liu X, Wan S, Jian L, et al. Role of Ca²⁺-Dependent Epithelial-Mesenchymal Transition in Malignant Progression of Colorectal Cancer: Special Focus on REG Iα/EDNRB. 2026. PubMed ID: 41972476. https://pubmed.ncbi.nlm.nih.gov/41972476/

  4. Li S, Chen A, Guo C, et al. TLN1 interacts with NGFR and suppresses the development of castration-resistant prostate cancer by upregulating NGFR. 2026. PubMed ID: 42112334. https://pubmed.ncbi.nlm.nih.gov/42112334/

  5. Prismasari S, Kim HJ, Hong JH, et al. Therapeutic Potential of Allomyrinasin in Oral Squamous Cell Carcinoma via Decreased NBC Activity. 2026. PubMed ID: 42198315. https://pubmed.ncbi.nlm.nih.gov/42198315/

  6. CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. U.S. Department of Health and Human Services, 2020. https://www.cdc.gov/labs/bmbl/index.html

  7. National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules/

  8. National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. https://www.ncbi.nlm.nih.gov/books/

Related Articles